NYSE: TEVA Investor Notice: Lawsuit Alleges Securities Laws Violations by Teva Pharmaceutical Industries Limited
An investor, who purchased shares of Teva Pharmaceutical Industries Limited (NYSE: TEVA), filed a lawsuit over alleged violations of Federal Securities Laws by Teva Pharmaceutical Industries Limited in connection with certain allegedly false and misleading statements.
View full press release